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Abstract
Background:  N-chlorotaurine, a long-lived oxidant produced by human leukocytes, can be
applied in human medicine as an endogenous antiseptic. Its antimicrobial activity can be enhanced
by ammonium chloride. This study was designed to evaluate the tolerability of inhaled N-
chlorotaurine (NCT) in the pig model.
Methods: Anesthetized pigs inhaled test solutions of 1% (55 mM) NCT (n = 7), 5% NCT (n = 6),
or 1% NCT plus 1% ammonium chloride (NH4Cl) (n = 6), and 0.9% saline solution as a control (n
= 7), respectively. Applications with 5 ml each were performed hourly within four hours. Lung
function, haemodynamics, and pharmacokinetics were monitored. Bronchial lavage samples for
captive bubble surfactometry and lung samples for histology and electron microscopy were
removed.
Results: Arterial pressure of oxygen (PaO2) decreased significantly over the observation period
of 4 hours in all animals. Compared to saline, 1% NCT + 1% NH4Cl led to significantly lower PaO2
values at the endpoint after 4 hours (62 ± 9.6 mmHg vs. 76 ± 9.2 mmHg, p = 0.014) with a
corresponding increase in alveolo-arterial difference of oxygen partial pressure (AaDO2) (p =
0.004). Interestingly, AaDO2 was lowest with 1% NCT, even lower than with saline (p = 0.016).
The increase of pulmonary artery pressure (PAP) over the observation period was smallest with
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1% NCT without difference to controls (p = 0.91), and higher with 5% NCT (p = 0.02), and NCT
+ NH4Cl (p = 0.05).
Histological and ultrastructural investigations revealed no differences between the test and control
groups. The surfactant function remained intact. There was no systemic resorption of NCT
detectable, and its local inactivation took place within 30 min. The concentration of NCT tolerated
by A549 lung epithelial cells in vitro was similar to that known from other body cells (0.25–0.5 mM).
Conclusion: The endogenous antiseptic NCT was well tolerated at a concentration of 1% upon
inhalation in the pig model. Addition of ammonium chloride in high concentration provokes a
statistically significant impact on blood oxygenation.
Background
N-chlorotaurine (Cl-HN-CH2-CH2-SO3
-), the N-chloro
derivative of the amino acid taurine, is a long-lived oxi-
dant produced by activated human granulocytes and
monocytes [1], and in low concentration probably also in
macrophages [2]. It is the main representative of chlo-
ramines, i.e. oxidizing R-NHCl compounds, created dur-
ing the oxidative burst [3]. Its main functions in vivo are
thought to be detoxification of HOCl by its formation
(reaction of HOCl with taurine) [1,3] and termination of
inflammation by downregulation of proinflammatory
cytokines and interleukins [4,5], but also activation of
white blood cells to eradicate pathogens is conceivable
(Giese T, Meuer S, Heidelberg, personal communication).
Eventually, the synthesis of the pure crystalline sodium
salt of N-chlorotaurine (NCT, molecular weight 181.57 g/
mol) in our laboratory succeeded [6]. A 90% stability of
both the pure product and the aqueous solution at 2–4°C
per year makes it suitable for practical use [6]. This facili-
tated a comprehensive investigation of its antimicrobial
properties. Studies disclosed broad spectrum bactericidal
(Gram-positive and Gram-negative bacteria), fungicidal
(yeasts and moulds) and virucidal activity of NCT [7-10]
without development of resistance [7].
The activity of NCT against bacteria and fungi could be
significantly enhanced by addition of ammonium chlo-
ride (NH4Cl) [7,10]. This phenomenon is caused by chlo-
rine transfer from NCT to ammonium
("transhalogenation") at which the lipophilic and there-
fore stronger microbicidal monochloramine (NH2Cl) is
formed [3,7]. As a consequence, the activity of NCT
against bacteria and particularly fungi is higher in inflam-
matory exudates than in buffer solution since the exudates
contain ammonium [10].
The antimicrobial and immune-modulatory features
encouraged investigations of the usability of 1% (55 mM)
NCT solution as a topical antiseptic for the treatment of
infections in human medicine. Promising indications
proved to be conjunctivitis [11,12], purulent crural ulcer-
ations[13], and otitis externa [14]. In a rabbit viral con-
junctivitis model some efficacy of NCT and superior
efficacy of NCT plus ammonium chloride was found [11].
In mouse models, NCT was beneficial in experimentally
induced arthritis [15,16].
For deep airway infections, inhalative therapy with antibi-
otics is performed in some special cases (e.g. Pneumo-
cystis jirovecii and cystic fibrosis) [17], but may also be
beneficial in further indications [18]. Therapeutic and
prophylactic inhalative use of a well-tolerated antiseptic
in bronchopulmonary infections may be an interesting
perspective. NCT as an endogenous compound anyway
present in small amounts at inflammatory sites including
the bronchi [19] may meet these requirements. Its forma-
tion has been shown to detoxify hypochlorous acid (tau-
rine + HOCl → NCT + H2O) and to protect lung epithelial
cells by this mechanism [20]. The ciliary beat frequency, a
very sensitive parameter for testing toxicity, of mucosa
samples gained from the nasal cavity upon conchotomy
was only minimally and reversibly influenced by 20 min
in 1% NCT, while an anaesthetic solution used in the eve-
ryday otorhinolaryngological practice caused a marked
and irreversible reduction [21].
Recently, a pig model at our university has been estab-
lished for investigation of the acute respiratory distress
syndrome [22-24]. This model can be used for testing sub-
stances applied as aerosol via an inhalation device. Thera-
peutic effects can be detected within short time in this
model [22,25], and it was found suitable for our investi-
gations.
The aim of this study was to investigate the tolerability of
inhaled NCT in our pig model. In addition, the combina-
tion of NCT and ammonium chloride was tested.
Methods
Test solutions
Pure NCT as a crystalline sodium salt (molecular weight
181,57) was prepared according to [6]. Purity was proved
by spectrophotometry [6]. Ammonium chloride at theBMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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highest available purity was purchased from Merck
(Darmstadt, Germany). Reagents were dissolved in sterile
and pyrogen-free distilled water to solutions with a final
concentration of 1% NCT (55 mM), 5% NCT (275 mM)
as well as 1% NCT plus 1% NH4Cl (187 mM). Solutions
were prepared as required, sterile-filtered and stored at 2–
4°C for maximally one week. To warrant double-blinding
they were filled in similar flasks than sterile and pyrogen-
free saline which served as a control. All flasks were num-
bered consecutively in accordance with the randomiza-
tion code.
Animals
The experiment was approved by the Austrian Federal Ani-
mal Investigational Committee, and animals were man-
aged in accordance with the National Institutes of Health
guidelines http://grants.nih.gov/grants/olaw/olaw.htm.
Healthy, 4-week-old white farm pigs were used in the
study. They were anesthetized during the whole experi-
ment.
Study design and treatment
The pigs were randomly assigned to one of the three test
groups (1% NCT, 5% NCT, 1% NCT plus 1% NH4Cl) or
to the control group (0.9% saline). Six animals per group
were included plus 1 animal per group as a reserve. Maxi-
mally 2 pigs were treated and evaluated on the same day.
Application of test solutions and measurements of evalu-
ation parameters were performed in a blinded way. Thirty
min after anaesthesia (see below), baseline parameters
were recorded. Again 30 min later, the first inhalation was
performed, followed by three further inhalations at inter-
vals of 1 hour with 5 ml of one of the test substances or
saline. One hour after the last inhalation the animals were
euthanized, and lung samples were removed. Parameters
of oxygenation and circulation were monitored. Baseline
values and values every 30 min after the first inhalation
were recorded. Blood samples were also taken at the base-
line, 2 h later, and 30 min after the last inhalation.
Anaesthesia of pigs
Anaesthesia was induced with ketamine (50 mg/kg IM)
and atropine (0.01 mg/kg IM), followed by intravenous
propofol (2 to 4 mg/kg). After the trachea had been intu-
bated, lungs were ventilated in volume controlled mode
(Evita 4, Dräger) at an inspiratory fraction of oxygen
(FIO2) of 0.4 and a tidal volume (VT) of 10 mL/kg at 20
breaths/minute, positive end expiratory pressure set at 5
cm H2O. Tidal volume was then adjusted to achieve an
arterial pressure of carbon dioxide (PaCO2) between 35
and 40 mm Hg, resulting in a minute ventilation of 150
to 170 mL/kg·min-1. Anaesthesia was maintained with
propofol (10 to 15 mg/kg/h) and piritramide boluses (15
mg each). Ringer's solution (6 mL/kg/h) and a 3% gela-
tine solution (4 mL/kg/h) were administered throughout
the procedure. A standard lead II ECG was used to moni-
tor cardiac rhythm. Body temperature was maintained
between 38°C and 39°C by using an electric heating blan-
ket.
Animal instrumentation
Venous catheters were inserted percutaneously into auric-
ular veins for inert gas infusion and continuous infusion
of propofol. A no. 7F thermistor-tipped Swan-Ganz cath-
eter (Baxter Edwards, Irvine, CA) was inserted into the
right jugular vein and advanced into a main pulmonary
artery by use of direct-pressure monitoring. This allowed
measurement of cardiac output, PAPM, and mixed venous
blood sampling. The left femoral artery was cannulated
for measurement of systemic pressure and arterial blood
gas sampling.
Haemodynamic measurements
Mean arterial blood pressure (MAP), central venous pres-
sure (CVP), and pulmonary artery occlusion pressure
(PCWP) were measured with an ICU monitor (Servomed;
Hellige GmbH, Frieburg, Germany) with standard pres-
sure transducers (model 1290A; Hewlett-Packard, Böblin-
gen, Germany) that had been zeroed to the level of the
right atrium. Cardiac output was measured with a Baxter-
Vigilance Monitor (Edwards Critical Care Division, Irvine,
CA) and a no. 7F Swan-Ganz catheter. The mean of four
determinations of cardiac output was recorded. Pulmo-
nary and systemic vascular resistance (PVRI, SVRI) was
calculated using standard formulas. Normalized values
were calculated by using a converting factor of
0.0947·kg2/3 [26].
Blood Gas and Metabolic Measurements
Arterial and mixed venous samples (2 ml each) were col-
lected simultaneously and immediately analyzed for oxy-
gen and carbon dioxide partial pressure, pH,
haemoglobin concentration, and haematocrit.
Respiratory Measurements
Airway pressures, expiratory tidal volume, expiratory
minute volume, and respiratory rate values were recorded
by the built-in detectors of the ventilator. Ventilation-per-
fusion distributions were determined using the multiple
inert gas elimination technique (MIGET) [27,28].
Protocol
After instrumentation of the animals and a stabilization
phase of 30 minutes, baseline measurements (haemody-
namics, blood gases) were taken. Each set of measure-
ments included heart rate, MAP, and CVP, mean
pulmonary arterial pressure (PAPM), and PCWP. Inert gas
as well as arterial and mixed venous blood gas samples
were taken at the same time.BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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Inhalation was carried out by an ultrasonic nebulizer
(OPTINEB®-ir Modell/Type: ON-100/2–2.4 MHz from
NEBU-TEC med. Produkte Eike Kern GmbH, Elsenfeld,
Germany). Delivery of the aerosol was provided during
the inspiration phase by side port connection to the
inspiratory side of the Y-piece. At the end of the experi-
mental runs, animals were killed using pentobarbital.
Pharmacokinetics of NCT
To address systemic uptake of NCT, the taurine concentra-
tion in the serum was determined at the baseline, after 2
inhalations and 30 min after the last inhalation. If NCT in
amounts used for inhalation comes into contact with
blood, it is immediately inactivated by thio groups and
degrades into taurine and chloride. Therefore, taurine is
an ideal measure for systemic uptake of topically applied
NCT. Taurine was analyzed by ion-exchange chromatog-
raphy with ninhydrin detection (AminoTac, JLC-500/V,
Jeol) [29]. Since the machine automatically provides the
results, we evaluated 28 further amino acids in total.
To address the local pharmacokinetics in the lung, imme-
diately after euthanizing the animals, the chest was
opened and a peripheral bronchus was irrigated with 10
ml of saline. Potassium iodide was added in excess, and
the formed coloured tri-iodide was measured spectropho-
tometrically at 350 nm, its maximum wavelength
(absorption coefficient 22900/mol/cm [1]).
Histology
Subsequent to euthanizing the animal, artificial ventila-
tion was continued up to removal of lung samples of the
upper and lower lobes. Lung tissue was subjected to histo-
logical processing according to standard procedures as fol-
lows: (i) formalin fixation and paraffin-embedding; (ii)
freezing with isopentane-N2, and storage at -70°C: (iii)
fixation with glutaraldehyde (2%). Moreover, fresh tissue
was used to extract protein, DNA and RNA according to
commercial kits instructions. The tissue was routinely
stained with haematoxylin and eosin, periodic acid Schiff
(glycogen staining), elastica van Gieson (elastic fibers of
the intrapulmonary blood vessels), and reticulin (reticu-
lin fibers). The haematoxylin-eosin staining was used to
evaluate the infiltration with neutrophilic granulocytes,
eosinophilic granulocytes, lymphocytes, erythrocytes,
atelectasis, bronchiolitis, bronchitis, lymphangiectasia,
and capillary congestion. The PAS staining was used to
evaluate the variability of the amount of goblet cells,
mucus, detachment of epithelial cells and epithelial
changes. The elastica van Gieson was used to detect the
fragmentation of the external and internal laminae of the
blood vessels. The reticulin staining was used to detect
collapse of fibers, thinning or thickening of the alveolar
septa, the presence of emphysema, bullae and thickening
of the pleura.
Electron Microscopy
Transmission electron microscopy (TEM) was used to
evaluate possible effects of NCT to subcellular constitu-
ents (organelles, endomembranes, cytoskeleton). Small
pieces from swine lung (approximately 1 mm in diame-
ter) were collected immediately after slaughtering and
fixed in 1% phosphate buffered glutaraldehyde for at least
24 hours. After post fixation in a 1% aqueous osmium
solution the probes were dehydrated in a graded series of
ethyl alcohol (30, 50, 70, 90, 3 × 100%) and finally
embedded in epoxy resin (Fluka, Germany).
Thin sections were prepared with a Reichert Jung Ultracut
E (Leica Instruments, UK) mounted on formvar coated
copper grids (Polysciences, USA) and counterstained with
uranyl acetate and lead citrate. Ultrastructural investiga-
tions were performed with a Zeiss EM 109 (Zeiss, GER).
Micrographs were taken on ILFORD PAN F 50 negative
film and digitalized with a Nikon ED 9000 film scanner
(Nikon, JPN). Since manual measurement can be error-
prone, we used an operator-interactive, semi-automated
method using ImageJ http://rsb.info.nih.gov/ij/, an open-
source platform running on Windows® environment [30].
In situ determination of cytokines
Expression of interleukins (IL) IL-1, IL-8, TNF-α, and
haem oxygenase 1 was investigated by mRNA analysis
according to [31].
Real-Time RT-PCR
Biopsies were collected in RNAlater (Ambion, Austin, TX,
USA), and stored at -20°C until analysis. Tissue was dis-
rupted by 3 to 4 runs with the RiboLyser (ThermoHY-
BAID, Heidelberg) in lysing matrix „D” tubes (Q-BIOgen,
Heidelberg) containing 400 μl lysis buffer from the Mag-
naPure mRNA Isolation Kit II (ROCHE Diagnostics, Man-
nheim). 300 μl of the lysate was collected and mixed with
600 μl capture buffer containing oligo-dT. After centrifu-
gation at 13000 rpm for 5 min, 880 μl of this mix was
transferred into a MagnaPure sample cartridge and mRNA
was isolated with the MagnaPure-LC device using the
mRNA-II standard protocol. The elution volume was set
to 50 μl.
An aliquot of 8.2 μl mRNA was reversely transcribed using
AMV-RT and oligo-(dT) as primer (First Strand cDNA syn-
thesis kit, Roche) according to the manufactures protocol
in a thermocycler. After termination of the cDNA synthe-
sis, the reaction mix was diluted to a final volume of 500
μl and stored at -20°C until PCR analysis. Primer sets for
pig GAPDH, IL-1b, IL-8, HO-1 and TNF-alpha optimized
for the LightCycler®  (RAS, Mannheim Germany) were
developed and purchased from SEARCH-LC GmbH, Hei-
delberg. The PCR was performed with the LightCycler®
FastStart DNA Sybr GreenI kit (RAS) according to the pro-BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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tocol provided in the parameter specific kits. To control
for specificity of the amplification products, a melting
curve analysis was performed. The copy number was cal-
culated from a standard curve, obtained by plotting
known input concentrations of four different plasmids at
log dilutions to the PCR-cycle number (CP) at which the
detected fluorescence intensity reaches a fixed value. This
approach dramatically reduced variations due to handling
errors over several logarithmic dilution steps. To correct
for differences in the content of mRNA, the calculated
copy numbers were normalized according to the average
expression of the housekeeping gene GAPDH. Values
were thus given as input adjusted copy number per μl of
cDNA.
Influence of the inhalations on the surfactant
Captive bubble surfactometry was performed to evaluate
the function of the surfactant. Immediately after euthana-
sia, a bronchus was irrigated with 10 ml saline, and the
lavage fluid was collected (bronchiolo-alveolar lavage,
BAL). BAL samples were collected, spun and kept frozen at
-20°C before use. Because of the high efforts for this
method, only a total of six samples could be investigated,
two from the NCT + NH4Cl, two from the saline, and one
each from the 1% NCT and 5% NCT group. As an internal
quality control, three measurements using porcine sur-
factant (Curosurf®, 80 mg/ml stock solution) were per-
formed.
The phospholipid concentration was determined, and all
samples and controls were diluted with TRIS-buffer
(Sigma) to a concentration of 1 mg/ml lecithin. 70 μl
CurosurfR had to be diluted with 3930 μl buffer. Measure-
ments of quasi-static surface tension measurements of
BAL were performed with captive bubble surfactometry
[32]. For film formation a 5-min adsorption period fol-
lowed the introduction of the bubble in to the chamber
filled with BAL. Furthermore, for 5 quasi static cycling the
bubble was first reduced and then enlarged in a stepwise
fashion between 0.5 and 2.5 atm. During the experiment,
the chamber was kept at 37°C. Bubble volume, area and
surface tension (γ) were calculated from digitized bubble
images using height and diameter [33].
In-vitro toxicity tests
Lung epithelial cells (type II alveolar epithelial cell line
A549, CCL-185, [34,35]) were grown in RPMI 1640
medium plus 10% fetal calf serum in cell culture flasks.
Subcultures were grown in 96 well microtitre plates,
washed two times with PBS and incubated in 100 μl PBS
containing 0.1 – 55 mM (0.002 – 1.0%) NCT, 0.1 – 1 mM
NCT plus 0.37 – 3.74 mM (0.02 – 0.002%) ammonium
chloride for 30 min at 37°C and pH 7.4. Subsequently,
cell viability was evaluated by trypan blue exclusion tests
and by CellTiter 96 Aqueous One Solution Cell Prolifera-
tion Assay (Promega Corporation, Madison, USA) in sep-
arate experiments. In the cell proliferation assay, 20 μl
MTS solution [3-(4,5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium] was added and the cells were incubated for further
3 h. Then the formed formazan was quantified spectro-
photometrically at 490 nm according to the instructions
of the manufacturer. Controls were performed with PBS
without additives, 1% taurine, and 1% ammonium chlo-
ride.
Statistical Analysis
For haemodynamics, blood gas and respiratory measure-
ments a two-way analysis of variance was used to deter-
mine inter- and intragroup differences. Significant
differences were post-hoc  analyzed with the Newman-
Keuls test. Data are presented as mean ± SD. One-way
ANOVA and Dunnett's multiple comparison test were
applied for in-vitro toxicity tests. Chi-square and Fisher's
test were used for evaluation of changes found in histol-
ogy. Descriptive statistics were applied for electron micro-
scopy and surfactometry. Cytokines were evaluated by
standard statistical nonparametric tests for group differ-
ences, and correlations were performed using the software
package SPSS 13 for MacOSX. p < 0.05 was considered sig-
nificant for all tests.
Results
Pulmonary gas exchange
The following parameters of pulmonary gas exchange
turned out as the most sensitive ones to detect any impact
of the inhaled test substances.
Arterial partial pressure of oxygen (PaO2) values at base-
line were within normal range in all animals without any
intergroup difference (97 mmHg ± 7.6), reflecting
healthy, anesthetized and ventilated animals. PaO2
decreased significantly over the observation period of 4
hours in all animals (Figure 1). No difference in PaO2 to
controls was seen in those animals receiving 1% NCT or
5% NCT, whereas inhalation with 1% NCT + 1% NH4Cl
led to significantly lower PaO2 values (62 ± 9.6 mmHg vs.
76 ± 9.2 mmHg, p = 0.014 after 4 h).
Alveolo-arterial difference of oxygen partial pressure
(AaDO2) correspondingly increased in all animals during
the experimental periode and was highest in the NCT +
NH4Cl group (9.0 ± 7.2 at the baseline to 45.7 ± 8.73 after
4 h, p = 0.00014), Figure 2. After 4 hours, AaDO2 was sig-
nificantly higher in the NCT + NH4Cl group (p = 0.004),
but not different from controls in the 5% NCT group. In
sharp contrast, AaDO2 was even lower in the 1% NCT
group (21.0 ± 13.09 vs. 33.7 ± 9.03, p = 0.016). Mixed
venous PO2  did not differ in the animals (37 ± 2.9
mmHg) and no change was observed during the experi-BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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mental period. PaCO2 levels stayed within normal range
(37 ± 2.8 mmHg), entirely without any inter- or intra-
group changes.
The pressure of mechanical ventilation was started with
mean values between 23.2 and 23.7 mmHg in all groups.
To control for physiological end-tidal CO2-levels at 4 h, a
positive inspiratory pressure of 30.0 ± 5.2 was necessary
for the control animals, 30.3 ± 7.5 for 1% NCT, 32.8 ± 6.4
for 5% NCT, and 34.2 ± 4.8 for NCT + NH4Cl animals,
respectively. The differences were not significant (p > 0.1),
though the values might also indicate a smaller effect of
1% NCT on gas exchange than 5% NCT and the combina-
tion. Ventilation-perfusion distributions determined with
MIGET showed no differences between the test (normal
VA/Q of Q ratio after 4 hours 97% for 1% NCT, 95% for
5% NCT) and control groups (96%), except for NCT +
NH4Cl (86%, p < 0.05).
Haemodynamics
Pulmonary artery pressure as a further highly sensitive
parameter for functional pulmonary disorders increased
over the observation period in all animals (from 22.0 ±
2.2 mmHg to 28.7 ± 3.6 mmHg in controls). 1% NCT
showed the smallest increase of PAP without difference to
saline (p = 0.9), while it was higher after 4 hours with 5%
NCT (p = 0.02) and NCT + NH4Cl (p = 0.05) (Figure 3).
Systemic arterial pressure remained constant within phys-
iological range over the entire experimental period in all
animals alike without any inter-or intragroup differences.
Heart rate at the 4 hours measurement was not signifi-
cantly different from controls in both NCT groups,
whereas it significantly increased by NCT + NH4Cl (104 ±
5.4/min to 136 ± 16.9/min, p = 0.00002), resulting in a
significant difference to controls after 4 hours (111 ±
21.3/min, p = 0.00036).
Pharmacokinetics
The taurine levels in serum ranged between 110 and 186
μM (0 h), and 85 and 172 μM (4 h), and they did not
increase in any of the test groups and in the control group.
However, the cystine levels increased significantly in the
pigs treated with 5% NCT from 35.5 ± 7.9 μM (0 h) to
52.7 ± 4.2 μM (2 h) and 51.9 ± 6.2 μM (4 h) (p < 0.01),
while they remained constant in all other animals. No
changes were observed in further 27 amino acids com-
pared to the controls.
Arterial partial pressure of oxygen (PaO2) of the pigs during  the inhalation period Figure 1
Arterial partial pressure of oxygen (PaO2) of the pigs 
during the inhalation period. Mean values ± SEM of 6–7 
animals. P = 0.014 between the control and 1% NCT + 1% 
NH4Cl, p > 0.05 between all other groups. * p < 0.05 for sin-
gle values; ** p < 0.01 for single values compared to the con-
trol.
Alveolo-arterial difference of oxygen partial pressure  (AaDO2) of the pigs during the inhalation period Figure 2
Alveolo-arterial difference of oxygen partial pressure 
(AaDO2) of the pigs during the inhalation period. 
Mean values ± SEM of 6–7 animals. p < 0.01 for 1% NCT + 
1% NH4Cl compared to saline and 1% NCT; p < 0.05 (0.016) 
between saline and 1% NCT. * p < 0.05 for single values; ** p 
< 0.01 for single values compared to the control.
Pulmonary artery pressure (PAP) of the pigs during the inha- lation period Figure 3
Pulmonary artery pressure (PAP) of the pigs during 
the inhalation period. Mean values ± SEM of 6–7 animals. 
p < 0.01 for 1% NCT + 1% NH4Cl and 5% NCT compared to 
saline and 1% NCT; p > 0.05 between saline and 1% NCT. * 
p < 0.05 for single values; ** p < 0.01 for single values com-
pared to the control.BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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We could not detect oxidation capacity in bronchial lav-
age performed immediately after euthanizing the animals.
Therefore, local inactivation of NCT below detectable lev-
els took place within 30 min.
Histology
Histological investigations revealed signs for inflamma-
tory reactions in all groups. However, there were no statis-
tical differences between the test groups and the control
group. Results are detailed in Table 1. In two animals
treated with 5% NCT detached epithelial cells were found,
which was not the case in the other groups (p = 0.065).
Electron microscopy
There were no ultrastructural changes of any cell type in
transmission electron microscopy. Apart of a focal
decrease of cristae, mitochondria were unremarkable in
all groups, no lysosomal activation was also seen. Moreo-
ver, we found no differences in the thickness of the basal
membranes in all groups examined. The thickness of the
basal membrane showed an overall range of 95 ± 2 nm
and the variability of the membrane thickness was compa-
rable in all groups with values between 92 and 99 nm. In
particular, in the 1% NCT group the basal membrane
thickness was 95 ± 2 nm, in the 5% NCT group 93 ± 2.6
nm, in the 1% NCT plus 1% NH4Cl group 96 ± 2.8 nm,
and in the saline group was 94 ± 2 nm. No clear evidence
of hyperplasia of pneumocyte type II was found in any
group.
In situ determination of cytokines
From each animal two samples were analyzed, biopsies
near the carina and from peripheral lung tissue. In 12 out
of the 56 samples no sufficient mRNA could be isolated,
most likely due to mRNA degradation in the sample. The
adjusted transcript values (number/μl cDNA) are listed in
Table 2. The expression of the investigated genes was
highly variable within each group and might reflect the
variable degree of inflammation observed in the histolog-
ical examination. This view is supported by a significant
Table 1: Number of animals with histological changes in the lung subsequent to the inhalations
NaCl
(n = 7)
1% NCT
(n = 7)
5% NCT
(n = 6)
1% NCT + 1% NH4Cl
(n = 6)
HE
Infiltration with 4 1 3 2
Neutrophilic granulocytes 4 5 5 3
Eosinophilic granulocytes 2 2 1 0
Lymphocytes 4 6 5 3
Erythrocytes 3 5 2 3
Atelectasis 3 2 1 3
Bronchiolitis 3 2 4 4
Bronchitis 6 2 * 2† 4
Lymphangiectasia 1 2 1 1
Capillary congestion 1 2 1 2
PAS
Goblet cells increased 4 5 2 2
Increased production of mucus 4 5 2 3
Detached epithelial cells 0 0 2‡ 0
Epithelial changes 0 0 1 0
Elastica
Fragmentation of lamina elastica 3 1 2 3
Fragmentation of lamina externa 1 0 0 0
Reticulin
Fibers collapsed 4 3 3 1
Thinned alveolar septa 3 2 2 3
Thickened alveolar septa 3 1 1 0
Emphysema 3 4 2 2
Bullae 1 2 1 2
Thickened pleura 1 0 0 0
* P = 0.051 versus control
† P = 0.08 versus control
‡ P = 0.065 versus control
P > 0.1 for all other frequencies versus controlBMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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correlation between the inflammatory markers within the
animals (with exception of the relation between HO-1
and TNFalpha) and the lack of significant differences
between the investigated groups (p > 0.1 versus control in
all cases). There was also a significant correlation in the
expression of HO-1, IL-1beta and IL-8 gene expression
between the samples taken near the carina and from
peripheral.
Surfactant
The surface tension under different pressure at the end of
the fifth quasi-static compression was similar in the con-
trol and test groups (Figure 4). The inclination of the
curves from control and test samples was equal (Figure 4).
NCT did not impact the function of surfactant. Minimal
surface tension values were relatively high, probably
because of the inflammation found with histology (see
above).
In-vitro toxicity tests
Lung epithelial cells (A549) tolerated 0.25 mM NCT for
30 min. There was > 95% viability in the trypan blue
exclusion test and no difference to the controls in the MTS
test. NCT (0.5 mM) caused a slight but significant
decrease of cell metabolism, while > 95% of the cells were
still viable by trypan exclusion. In the latter test, 50% of
the cells were killed by 1 mM, 83% (range 70–100%) by
11 mM, and > 95% by 55 mM NCT (mean values of 3
independent experiments). The corresponding loss of
metabolism is depicted in Figure 5.
Chloramine T, another active chlorine compound used in
human medicine, was investigated in parallel for compar-
ison using the trypan blue exclusion test. The tolerated
concentration of chloramine T, i.e. 0.01 mM, was 25-fold
lower than that of NCT. Higher concentrations of chlo-
ramine T led to 10–30% (0.1 mM), 50–100% (0.5 mM),
and > 95% loss of viability (1 mM) (range of 3 independ-
ent experiments).
Discussion
Being a mild endogenous oxidant, NCT proved to be an
antiseptic suitable for application to both the skin and
mucous membranes of different body cavities such as
paranasal sinuses [13,14,36,37]. The substance seems to
be particularly applicable to tissues for which other anti-
septics are avoided because of toxic side effects. Such a
field is inhalative application. For special indications aer-
osolized antibiotics and antifungals have been used suc-
cessfully, e.g. for treatment or prophylaxis of
Table 2: Gene expression by qRT-PCR in lung samples after inhalation, adjusted mRNA transcript values (number/μl cDNA)a
1% NCT 5% NCT NCT + NH4Cl NaCl
HO-1 near carina 2656
(1878)
1772
(1282)
3200
(3018)
1469
(1737)
peripheral 5003
(2608)
2833
(2639)
4300
(3416)
2044
(1717)
TNF alpha near carina 394.8
(157)
370.8
(190)
635.6
(440)
400.7
(198)
peripheral 214.6
(79)
185.2
(72)
243.0
(286)
344.6
(316)
IL-1-beta near carina 82.0
(104)
116.5
(87)
73.4
(39)
75.0
(139)
peripheral 77.8
(62)
58.3
(71)
247.6
(403)
164.0
(266)
IL-8 near carina 469.6
(395)
704.5
(991)
191.2
(93)
274.0
(475)
peripheral 846.2
(506)
772.5
(895)
1426.2
(1670)
779.0
(1187)
a mean values and (SD)
Surface tension of bronchial lavage samples under different  pressure measured by captive bubble surfactometry Figure 4
Surface tension of bronchial lavage samples under 
different pressure measured by captive bubble sur-
factometry. Mean values of two samples from pigs treated 
with NCT+NH4Cl and 0.9% NaCl, respectively. Single values 
from one pig treated with 1% NCT and 5% NCT, respec-
tively.BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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Pneumocystis jirovecii, Pseudomonas aeruginosa, and
fungal infections [17,18,38]. Because of some uncertain-
ties regarding efficacy and toxicity of the presently availa-
ble therapeutics, the development of improved
antimicrobial agents for inhalation seems to be sugges-
tive. Antiseptics may be of advantage because of their
broad-spectrum activity and largely the absence of antimi-
crobial resistance. Toxicity is a major point of concern
with these compounds when administered to body cavi-
ties, but NCT seems to be well tolerated in the bronchop-
ulmonary system according to our results.
Lung epithelial cells (A549) tolerated about 0.5 mM NCT
and were similarly susceptible as other body cells [13,39],
e.g. macrophages and keratinocytes. Moreover, our find-
ings are in accordance with a previous report where tau-
rine protected lung epithelial cells from HOCl-induced
injury by conversion of HOCl to the low toxic NCT [20].
It is very important to mention that the clinically applied
NCT concentration tolerated by different tissues is about
100-fold higher (55 mM) than that of monolayers in the
cell culture [13,20,39]. Therefore, cell culture systems are
useful for comparison of antiseptics (e.g. chloramine T
and NCT, [13]) and to predict to a certain extent in vivo
toxicity, as it was the case with NCT plus ammonium in
our study. However, it is finally decisive that a clinically
effective dose is tolerated in both animal models and in
man. As expected and similar to keratinocytes [13], the
stronger oxidant chloramine T damaged lung epithelial
cells much more than NCT.
We chose the pig model since it has high similarity to
human, ventilation and circulation parameters can be
monitored, inhalations can be performed in a similar
way, and sufficient amounts of serum and tissue can be
removed for evaluation. A limitation in our unit was that
the experimentation in each animal had to be performed
within one day, so that dosing and monitoring for longer
periods was not possible. This disadvantage may have
been compensated for to a certain degree by the per-
formed intensive treatment schedule.
In accordance with our previous clinical studies in both
human beings and in animals (e.g. [12-14,36,37,40-42],
the concentration of 1% NCT (55 mM) seems to be very
well tolerated also in the bronchopulmonary system. Also
the inhalative way has to be regarded as a topical one since
the amino acid concentrations in the blood, particularly
of taurine, did not change in all groups. This was the case
despite the high concentration gradient of taurine applied
locally (5% NCT equals 275 mM and 400 mM taurine
after reduction of the active chlorine) and in the serum of
the pigs (85–186 μM). The only hint for a small, negligi-
ble resorption of high inhaled concentrations could have
been the increase in cystine in the 5% NCT group. A theo-
retic explanation for that is oxidation of cysteine to cys-
tine, which takes place in the presence of NCT. It may be
that a minimal increase of taurine after application of 5%
NCT could not be detected within the standard deviation.
On the other hand, the blood level of methionine
remained constant, although it is oxidized by NCT, too.
Presently it can be stated that 1% NCT ± 1% NH4Cl does
not reach the circulation in detectable amounts, while
minimal amounts are possible with 5% NCT.
Since the reaction with thio groups leads to immediate
inactivation of NCT, the oxidative activity decreased
quickly and could not be measured in situ approximately
30 min after the last dosing. The short decomposition
time in vivo is in accordance with previous studies in the
eye (5–15 min, [36,43]). Longer times of a few hours are
only possible if a fluid level containing NCT is kept in
body cavities [37].
No tested clinical and laboratory parameter in the 1%
NCT group worsened more than in the saline group dur-
ing the experimental period. With inhalation of chlo-
ramine T, a markedly stronger active chlorine compound
than NCT, bronchopulmonary irritation and allergic sen-
sitization with asthmatic symptoms are known [44]. The
lower reactivity of NCT and the fact that it deals with an
Mitochondrial metabolism of A549 lung epithelial cells after  30 min incubation in NCT or NCTplus NH4Cl (N+N) at dif- ferent concentrations in PBS in vitro, evaluated by the MTS  test Figure 5
Mitochondrial metabolism of A549 lung epithelial 
cells after 30 min incubation in NCT or NCTplus 
NH4Cl (N+N) at different concentrations in PBS in 
vitro, evaluated by the MTS test. Mean values ± SEM of 
five independent experiments. ** p < 0.01 for this and lower 
values compared to the control (PBS without additives). Abs 
absorption at 490 nm.BMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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endogenous amino acid derivative are obviously decisive
for its improved tolerability. If the concentration was
increased to 5% in our pig model, only one parameter
(pulmonary artery pressure) worsened significantly com-
pared to placebo. A similarly high safety of NCT could be
found for instance in the eye [36], in the ear [45] and in
the cow udder [40], where concentrations of 3–10%
caused local irritation, too, but no severe or long-term side
effects. Allergic reactions against NCT seem improbable
since it is produced upon every inflammation by leuko-
cytes and it is a small molecule (amino acid derivative),
and such reactions have not yet been observed in clinical
studies.
As a more potent chloramine formulation and as a posi-
tive control, we chose a 1% combination of NCT and
ammonium chloride (NH4Cl). This leads to formation of
about 0.025% (4.9 mM) monochloramine (NH2Cl)
which is only little more reactive but significantly more
lipophilic than the hydrophilic NCT [46]. The conse-
quence is increased penetration of pathogens but also
body cells and tissue, which may be wanted in some indi-
cations, e.g. in the eye for treatment of viral conjunctivitis
[11,43]. The concentration of 1% of both constituents is
very high and cannot be applied to the eye, but a tenfold
dilution is very well tolerated [43]. As expected, in the pig
model oxygenation and perfusion parameters changed
after inhalation with 1% NCT + 1% NH4Cl compared to
saline and NCT. Since systemic absorption of NCT ±
NH4Cl was not detected and low amounts in the blood
would be inactivated immediately, these changes must
have been caused by direct impact on lung epithelial and
endothelial cells. We expected a thickening of basal mem-
branes, but there were no changes at all found by electron
microscopy. Therefore, functional abnormalities of the
lung cells must be assumed which did not lead to struc-
tural changes. In vitro, lung epithelial cells demonstrated
about tenfold higher sensitivity to NCT + NH4Cl than to
NCT, which is in accordance to the in vivo results, at
which the threshold tolerated concentration of the combi-
nation remains to be tested in vivo.
Histologic evaluation did not reveal an explanation for
the effects of 1% NCT + 1% NH4Cl and 5% NCT, too. The
abnormalities found, mainly infiltration with leukocytes,
and local atelectasis and emphysema, are well known to
occur during the anaesthesia of pigs [47]. It cannot be
excluded that these changes might have overlapped and
masked minimal ones caused by the test medication. In
any case the absence of a significant impact clearly visible
in histology indicates the relatively high tolerance of NCT
with and without NH4Cl by tissue.
Furthermore, the function of surfactant seems not to be
significantly influenced by the medication. It is true that
the test procedure using the captive bubble surfactometer
is very complicated, laborious, and affected with high
deviations, and it was possible to perform only a few tests
in the present study. Therefore, small differences between
the tested groups cannot be excluded, but a massive
destruction of surfactant or its producing cells did not take
place. This would have caused much more intensive clin-
ical problems. In accordance with that, NCT as a mild
active chlorine compound mainly reacts with thio and
amino groups [6] and has no targets with the phospholi-
pid constituents of surfactant which are important for its
function [48].
The fact that one oxygenation parameter (AaDO2) was
even significantly better at the end of the applications in
the pigs treated with 1% NCT compared to saline may be
regarded as pure chance. On the other hand, anti-inflam-
matory effects might be caused by NCT since in its pres-
ence proinflammatory cytokines and interleukins have
been shown to be produced in lower amounts by stimu-
lated leukocytes in vitro [4,5,16]. Some effects in part con-
trasting these results have also been found, i.e. significant
induction of IL-1beta, IL-8, TNF-alpha and HO-1 gene
expression in human PBMC (Giese T, Heidelberg, unpub-
lished results). When NCT was applied to treat infections
in our clinical studies, specific investigations to quantify a
possible anti-inflammatory effect and to differentiate it
from the antimicrobial one have not been performed.
Some signs for clinically relevant anti-inflammatory
effects may be derived from phase 2a studies on chronic
rhinosinusitis and, above all, postoperative ear care after
tympanoplasty, where deswelling and drying effects were
found in the absence of infection [37,41]. In the present
study we tried to address this question specifically for the
first time in vivo by measurements of IL-1beta, IL-8, TNF-
alpha and HO-1 gene expression. However, no conclusive
results could be gained from lung tissue in vivo. As
observed during histo-pathological examination, the
experimental procedure triggered a variable degree of
injury-associated inflammation in the lung tissue. This
reaction might have overridden the more subtle changes
caused by NCT and NCT+NH4Cl. However, this hypothe-
sis could not be proven in the experiment due the limited
number of investigated samples.
Summing up, inhaled NCT at a concentration of 1% was
well tolerated in the pig model. Further investigations of
its tolerability in human beings and on its possible effi-
cacy in the infected bronchopulmonary system are justi-
fied.
Conclusion
The antiseptic NCT was well tolerated at a concentration
of 1% upon inhalation in the pig model, while 5% dem-
onstrated small effects on pulmonary artery pressure, andBMC Pulmonary Medicine 2009, 9:33 http://www.biomedcentral.com/1471-2466/9/33
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1% NCT + 1% NH4Cl small effects on gas exchange and
haemodynamics. Therefore, 1% NCT may be suitable for
inhalative application, while for the combination with
ammonium a dose reduction is probably required.
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